Rare diseases
Investigational molecules
Locations
Back to France26 clinical trials in Bois-Guillaume, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness of Ceftriaxone and Metronidazole Combination for Patients with Hurley Stage 2 Hidradenitis Suppurativa
FrancePhase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4
FranceTesting avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage
FranceStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
FranceWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
FranceStudy of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)
FranceStudy on Bezafibrate for Patients with Primary Sclerosing Cholangitis and Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy
FranceStudy on Nicotinamide for Preventing Kidney Problems in Septic Shock Patients
FranceStudy on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis
FranceStudy on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant
FranceStudy on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura
FranceStudy on Tegoprubart for Preventing Kidney Transplant Rejection in Patients
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic kidney disease treatments and transplant outcomes, including studies of novel medications like baxdrostat and tegoprubart for improving patient care.
Multiple trials evaluating new therapeutic approaches for transplant recipients and CKD patients.
Clinical investigations into treatments for various blood-related conditions, with emphasis on immune thrombocytopenia and thrombotic disorders.
Advanced studies combining established and experimental treatments for better patient outcomes.
Research examining treatment strategies for viral infections and optimization of antibiotic therapy, particularly in elderly populations.
Studies focused on improving treatment protocols and reducing antibiotic overuse.
Investigation of novel therapies for vasculitis and related autoimmune disorders, including targeted biological treatments.
Evaluating new treatment combinations to improve disease management and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
